MedImmune and the University of Cambridge today said they have launched a new five-year, multiproject collaboration with the school’s Department of Chemical Engineering and Biotechnology (CEB) focused on research in biopharmaceutical development including cell engineering. The value of the collaboration was not disclosed.
{iframe}http://www.genengnews.com/gen-news-highlights/medimmune-univ-of-cambridge-expand-collaboration/81251313/{/iframe}